Irlanti - englanti - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - ibandronate sodium monohydrate - film-coated tablet - 150 milligram(s) - bisphosphonates; ibandronic acid

Malta - englanti - Malta Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - ibandronic acid - film-coated tablet - ibandronic acid 150 mg - drugs for treatment of bone diseases

Australia - englanti - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - cyproterone acetate, quantity: 2 mg; ethinylestradiol, quantity: 35 microgram - tablet, sugar coated - excipient ingredients: macrogol 6000; lactose monohydrate; sucrose; povidone; purified talc; calcium carbonate; glycol montanate; maize starch; magnesium stearate - juliet-35 ed is indicated for: the treatment of signs of androgenisation in women, such as severe acne (involving inflammation or nodularity or risk of scarring) where prolonged oral antibiotics or local treatment alone has not been successful, or idiopathic hirsutism of mild to moderate degree. juliet-35 will also provide effective oral contraception in this patient group. it should not be used in combination with other hormonal contraceptives (see contraindications).,if the hirsutism has only recently appeared or has lately intensified to a considerable extent the cause (androgen-producing tumour or an adrenal-enzyme defect) must be clarified by differential diagnosis. the treatment of signs of androgenisation in women such as severe acne (involving inflammation or nodularity or risk of scarring) where prolonged oral antibiotics or local treatment alone has not been successful, or idiopathic hirsutism of mild to moderate degree. juliet-35 ed will also provide effective oral contraception in this patient group. if the hirsutism has only recently appeared or has lately intensified to a considerable extent the cause (androgen-producing tumour or an adrenal-enzyme defect) must be clarified by differential diagnosis.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - cyproterone acetate, quantity: 2 mg; ethinylestradiol, quantity: 35 microgram - tablet, sugar coated - excipient ingredients: povidone; calcium carbonate; maize starch; sucrose; lactose monohydrate; macrogol 6000; purified talc; magnesium stearate; glycol montanate - diane-35 ed is indicated for: the treatment of signs of androgenisation in women, such as severe acne (involving inflammation or nodularity or risk of scarring) where prolonged oral antibiotics or local treatment alone has not been successful, or idiopathic hirsutism of mild to moderate degree. diane-35 will also provide effective oral contraception in this patient group. it should not be used in combination with other hormonal contraceptives (see contraindications).,if the hirsutism has only recently appeared or has lately intensified to a considerable extent the cause (androgen-producing tumour or an adrenal-enzyme defect) must be clarified by differential diagnosis.

Yhdysvallat - englanti - NLM (National Library of Medicine)

the procter & gamble manufacturing company - aluminum zirconium tetrachlorohydrex gly (unii: 8o386558je) (aluminum zirconium tetrachlorohydrex gly - unii:8o386558je) - antiperspirant reduces underarm wetness

Singapore - englanti - HSA (Health Sciences Authority)

nipro asia pte ltd - gastroenterology & urology - this machine can be used for patients with acute or chronic renal failure and when hemodialysis is prescribed by a physician.

Yhdysvallat - englanti - NLM (National Library of Medicine)

wild child laboratories pty ltd - active ingredients: zinc oxide 22.75 %, sunscreen - use: helps prevent sunburn. if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin ageing caused by the sun. other information: protect this product from excess heat and direct sun. store below 30°c / 86°f

Australia - englanti - Department of Health (Therapeutic Goods Administration)

sunday supply co pty ltd - zinc oxide, quantity: 227.5 mg/g - cream - excipient ingredients: isostearic acid; coconut oil; polyglyceryl-3 polyricinoleate; d-alpha-tocopheryl acetate; medium chain triglycerides; castor oil; coco-caprylate; white beeswax - spf 50 broad spectrum high protection sunscreen

Yhdysvallat - englanti - NLM (National Library of Medicine)

wild child w a pty ltd - avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox) - sunscreen use: helps prevent sunburn. if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin ageing caused by the sun. do not use on damaged or broken skin if rashes occur

Yhdysvallat - englanti - NLM (National Library of Medicine)

wild child laboratories pty ltd - active ingredients: titanium dioxide 3.3% zinc oxide 14.9%, sunscreen - uses: helps prevent sunburn. if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin ageing caused by the sun. directions: shake well before use. apply liberally and reapply every 80 minutes, especially after swimming or towel drying. sun protection measures spending time in the sun increases your risk of skin cancer and early skin aging. to decrease this risk, regularly use a sunscreen with a broad spectrum spf value of 15 or higher and other sun protection measures including: limit lime in the sun, especially from 10 am-2 pm wear longsleeved shirts, pants, hats, and sunglasses for children under 6 months of age ask a doctor sunscreen